Caribou Biosciences, Inc. (CRBU)
1.67
-0.09
(-5.11%)
USD |
NASDAQ |
Aug 26, 11:47
Caribou Biosciences 1 Year Total Returns (Daily) : -6.38% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | -6.38% |
| August 24, 2026 | -11.35% |
| August 21, 2026 | -9.78% |
| August 20, 2026 | -10.56% |
| August 19, 2026 | -7.34% |
| August 18, 2026 | -16.58% |
| August 17, 2026 | -20.71% |
| August 14, 2026 | -21.00% |
| August 13, 2026 | -17.44% |
| August 12, 2026 | -5.03% |
| August 11, 2026 | -1.17% |
| August 10, 2026 | -4.05% |
| August 07, 2026 | -8.84% |
| August 06, 2026 | -12.77% |
| August 05, 2026 | -21.08% |
| August 04, 2026 | -25.24% |
| August 03, 2026 | -23.08% |
| July 31, 2026 | -28.08% |
| July 30, 2026 | -26.34% |
| July 29, 2026 | -25.00% |
| July 28, 2026 | -34.93% |
| July 27, 2026 | -30.26% |
| July 24, 2026 | -33.76% |
| July 23, 2026 | -34.27% |
| July 22, 2026 | -29.96% |
| Date | Value |
|---|---|
| July 21, 2026 | -20.29% |
| July 20, 2026 | -20.98% |
| July 17, 2026 | -9.84% |
| July 16, 2026 | -9.29% |
| July 15, 2026 | 7.45% |
| July 14, 2026 | 2.94% |
| July 13, 2026 | 10.43% |
| July 10, 2026 | 10.63% |
| July 09, 2026 | 10.86% |
| July 08, 2026 | 21.25% |
| July 07, 2026 | 38.13% |
| July 06, 2026 | 33.58% |
| July 02, 2026 | 32.85% |
| July 01, 2026 | 40.80% |
| June 30, 2026 | 39.68% |
| June 29, 2026 | 40.48% |
| June 26, 2026 | 24.44% |
| June 25, 2026 | 10.56% |
| June 24, 2026 | 17.73% |
| June 23, 2026 | 25.76% |
| June 22, 2026 | 22.39% |
| June 18, 2026 | 28.12% |
| June 17, 2026 | 41.38% |
| June 16, 2026 | 50.89% |
| June 15, 2026 | 49.55% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Intellia Therapeutics, Inc. | 18.72% |
| Vir Biotechnology, Inc. | 144.5% |
| Arrowhead Pharmaceuticals, Inc. | 329.2% |
| Oncolytics Biotech, Inc. | -12.88% |
| Sangamo Therapeutics, Inc. | -72.93% |